Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals
Open Access
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (3), 214-220
- https://doi.org/10.1111/j.1469-0691.2004.01060.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- National Surveillance of Methicillin-Resistant Staphylococcus aureus in Belgian Hospitals Indicates Rapid Diversification of Epidemic ClonesAntimicrobial Agents and Chemotherapy, 2004
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsAntimicrobial Agents and Chemotherapy, 2003
- Epidemiological and Microbiological Characterization of Infections Caused byStaphylococcus aureuswith Reduced Susceptibility to Vancomycin, United States, 1997–2001Clinical Infectious Diseases, 2003
- The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus AureusAnnual Review of Microbiology, 2002
- Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical featuresJournal of Antimicrobial Chemotherapy, 2002
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus EndocarditisThe Journal of Infectious Diseases, 1990